FDA consults on SUDs (single use devices) labelling
This article was originally published in Clinica
The US FDA last week asked for help in sorting out an unresolved issue regarding its regulatory scheme for reprocessed single use devices (SUDs): that of how to handle mention of the original equipment manufacturer (OEM) in the labelling.
You may also be interested in...
Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business.
While Amgen said the Phase III GALACTIC-HF results for omecamtiv mecarbil did not meet its high expectations for the heart failure candidate, Cytokinetics sees a path to treating certain patients.
Lilly has launched a similar antibody product, but demand is expected to outpace supply for the foreseeable future.